Luckwel Pharmaceuticals Inc. (1567098) SEC Filing 10-K Annual report for the fiscal year ending Sunday, March 31, 2019

Luckwel Pharmaceuticals Inc.

CIK: 1567098
Document and Entity Information - USD ($)
12 Months Ended
Mar. 31, 2019
Jul. 01, 2019
Sep. 28, 2018
Document And Entity Information   
Entity Registrant NameLuckwel Pharmaceuticals Inc.  
Entity Central Index Key0001567098  
Document Type10-K  
Document Period End DateMar. 31, 2019  
Amendment Flagfalse  
Current Fiscal Year End Date--03-31  
Entity a Well-known Seasoned IssuerNo  
Entity a Voluntary FilerNo  
Entity's Reporting Status CurrentYes  
Entity Interactive Data CurrentYes  
Entity Filer CategoryNon-accelerated Filer  
Entity Small Business Flagfalse  
Entity Emerging Growth Companytrue  
Entity Ex Transition Periodfalse  
Entity Shell Companytrue  
Entity Public Float  $ 48,959,552
Entity Common Stock, Shares Outstanding 143,376,000 
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2019  

View differences made from one year to another to evaluate Luckwel Pharmaceuticals Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Luckwel Pharmaceuticals Inc..


Assess how Luckwel Pharmaceuticals Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Luckwel Pharmaceuticals Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1567098
Form Type: 10-K Annual Report
Accession Number: 0001493152-19-010056
Submitted to the SEC: Mon Jul 01 2019 5:32:34 PM EST
Accepted by the SEC: Tue Jul 02 2019
Period: Sunday, March 31, 2019
Industry: Pharmaceutical Preparations

External Resources:

Bookmark the Permalink: